This content was funded by UCB.
WATCH THE FULL VIDEO HERE >
Why wait to control inflammation? In this American College of Rheumatology (ACR) symposium, rheumatologist and immunologist Iain McInnes reviews the pathobiology of psoriatic disease and the clinical rationale for early, more complete control of inflammation in psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).
Topics covered:
- Multi-tissue disease burden and the importance of domain assessment
- Links between inflammatory burden, structural damage, function, and cardiovascular risk
- Cytokine signaling pathways in target tissues, including IL-23 and IL-17
- Tighter disease control, including targeting minimal disease activity (MDA), and the case for earlier intervention
Speaker:
Iain McInnes1
1. Vice Principal and Head of the College of Medical, Veterinary and Life Sciences, Muirhead Chair of Medicine and Versus Arthritis Professor of Rheumatology at the University of Glasgow.
US-DA-2501120
